TCAF 📈 T. Rowe Price - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Large Blend
TCAF: Equity, Stocks, Large, US, Companies, Technology, Healthcare
The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in equity securities. The fund may purchase the stocks of companies of any size, but typically focuses on large U.S. companies. The fund may at times invest significantly in certain sectors, including the information technology and healthcare sectors. It is non-diversified.
Additional Sources for TCAF ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TCAF ETF Overview
| Market Cap in USD | 2,905m |
| Category | Large Blend |
| TER | 0.31% |
| IPO / Inception | 2023-06-14 |
TCAF ETF Ratings
| Growth 5y | 79.3% |
| Fundamental | - |
| Dividend | 5.50% |
| Rel. Strength Industry | -13.6 |
| Analysts | - |
| Fair Price Momentum | 33.07 USD |
| Fair Price DCF | - |
TCAF Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 100.0% |
TCAF Growth Ratios
| Growth Correlation 3m | 71.9% |
| Growth Correlation 12m | 97.2% |
| Growth Correlation 5y | 96.3% |
| CAGR 5y | 20.06% |
| CAGR/Mean DD 5y | 13.90 |
| Sharpe Ratio 12m | 1.42 |
| Alpha | -1.75 |
| Beta | 0.92 |
| Volatility | 19.13% |
| Current Volume | 823.3k |
| Average Volume 20d | 749.6k |
What is the price of TCAF stocks?
As of December 22, 2024, the stock is trading at USD 33.69 with a total of 823,316 shares traded.
Over the past week, the price has changed by -3.23%, over one month by -0.83%, over three months by +0.85% and over the past year by +21.24%.
As of December 22, 2024, the stock is trading at USD 33.69 with a total of 823,316 shares traded.
Over the past week, the price has changed by -3.23%, over one month by -0.83%, over three months by +0.85% and over the past year by +21.24%.
Is T. Rowe Price a good stock to buy?
Yes. Based on ValueRay Analyses, T. Rowe Price (NYSE ARCA:TCAF) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 79.27 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TCAF as of December 2024 is 33.07. This means that TCAF is currently overvalued and has a potential downside of -1.84%.
Yes. Based on ValueRay Analyses, T. Rowe Price (NYSE ARCA:TCAF) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 79.27 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TCAF as of December 2024 is 33.07. This means that TCAF is currently overvalued and has a potential downside of -1.84%.
Is TCAF a buy, sell or hold?
T. Rowe Price has no consensus analysts rating.
T. Rowe Price has no consensus analysts rating.
What are the forecast for TCAF stock price target?
According to ValueRays Forecast Model, TCAF T. Rowe Price will be worth about 36.7 in December 2025. The stock is currently trading at 33.69. This means that the stock has a potential upside of +8.88%.
According to ValueRays Forecast Model, TCAF T. Rowe Price will be worth about 36.7 in December 2025. The stock is currently trading at 33.69. This means that the stock has a potential upside of +8.88%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 36.7 | 8.9% |